Justin Williams

SD Legislative Research Council

Hemp-derived cannabidiol, or CBD, is on its way to being clearly removed from a list of scheduled drugs in South Dakota.

The Health and Human Services Committee passed an amended bill on Wednesday, Jan. 23, to clear up concerns of hemp activists who testified last week against Senate Bill 22. They said the bill appeared to criminalize possession of hemp CBD without a prescription.

SDPB's Victoria Wicks reports.

LinkedIn

The Senate Health and Human Services Committee will reconsider a bill that regulates cannabidiol, or CBD, a Schedule IV drug in South Dakota.

That means CBD is available only by prescription.

Opponents to Senate Bill 22 say it criminalizes hemp CBD and prevents the state from exploring hemp as a crop. SDPB's Victoria Wicks has this report.